The document discusses key principles of Advanced Cardiac Life Support (ACLS). It emphasizes that excellent chest compressions are crucial, with minimal interruptions. Defibrillation for ventricular fibrillation and pulseless ventricular tachycardia should be performed as rapidly as possible. For asystole and pulseless electrical activity, chest compressions are the priority treatment while addressing any potentially treatable causes ("H's and T's") such as hypoxia, hypovolemia, etc. The document also reviews management of specific arrhythmias and considerations for termination of resuscitative efforts.
The document discusses key principles of Advanced Cardiac Life Support (ACLS). It emphasizes that excellent chest compressions are crucial, with minimal interruptions. Defibrillation for ventricular fibrillation and pulseless ventricular tachycardia should be performed as rapidly as possible. For asystole and pulseless electrical activity, chest compressions are the priority treatment while addressing any potentially treatable causes ("H's and T's") such as hypoxia, hypovolemia, etc. The document also reviews management of specific arrhythmias and considerations for termination of resuscitative efforts.
The document discusses key principles of Advanced Cardiac Life Support (ACLS). It emphasizes that excellent chest compressions are crucial, with minimal interruptions. Defibrillation for ventricular fibrillation and pulseless ventricular tachycardia should be performed as rapidly as possible. For asystole and pulseless electrical activity, chest compressions are the priority treatment while addressing any potentially treatable causes ("H's and T's") such as hypoxia, hypovolemia, etc. The document also reviews management of specific arrhythmias and considerations for termination of resuscitative efforts.
Excellent CPR & early defibrillation for treatable
arrhythmias remain the cornerstones of basic & ACLS. Cardiac Arrest, 4 rhythms In the past, clinicians frequently interrupted CPR to check for pulses, perform tracheal intubation, or obtain venous access.
The ACLS Guidelines strongly recommend that every effort
be made NOT to interrupt CPR; other less vital interventions (eg, tracheal intubation or administration of medications to treat arrhythmias) are made either while CPR is performed or during the briefest possible interruption.
Interventions that cannot be performed while CPR is in
progress (eg, defibrillation) should be performed during brief interruptions at two minute intervals (after the completion of a full cycle of CPR). Studies in both the in-hospital & prehospital settings demonstrate that chest compressions are often performed incorrectly, inconsistently, & with excessive interruption.
Chest compressions must be of sufficient depth
(at least 5 cm, or 2 inches) & rate (at least 100 per min), & allow for complete recoil of the chest between compressions, to be effective.
A single biphasic defibrillation remains the
recommended treatment for ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT). CPR should be performed until the defibrillator is ready for immediate discharge & resumed immediately after the shock is given, without pausing to recheck a pulse at that moment.
Interruptions in CPR (eg, for subsequent attempts at
defibrillation or pulse checks) should occur no more frequently than every two minutes, & for the shortest possible duration.
Patients are often over-ventilated during
resuscitations, which can compromise venous return resulting in reduced cardiac output & inadequate cerebral & cardiac perfusion. A 30 to 2 compression to ventilation ratio (one cycle) is recommended in patients without advanced airways.
According to the ACLS Guidelines, asynchronous
ventilations at 8 to 10 per minute are administered if an endotracheal tube or extraglottic airway is in place, while continuous chest compressions are performed simultaneously.
We believe that 6 to 8 ventilations per minute are
sufficient in the low-flow state of cardiac resuscitation & help to prevent over-ventilation. Key principles in the performance of ACLS Excellent CPR is crucial. •Excellent chest compressions must be performed throughout the resuscitation without interruption, using proper timing (100 compressions per minute) and force (≥5 cm depth), and allowing for complete chest recoil. •Do not stop compressions until the defibrillator is fully charged. •Anything short of excellent CPR does not achieve adequate cerebral and coronary perfusion. •Excellent chest compressions take priority over ventilation. If a second rescuer is present, ventilations must be performed using proper timing (6 to 8 breaths per minute in the intubated patient; ratio of 30 compressions to 2 ventilations if not intubated) and force (each breath delivered over a full 1 to 2 seconds); avoid hyperventilation.
Defibrillate VF and pulseless VT as rapidly as possible.
Rapidly identify and treat causes of non-shockable arrest (PEA, asystole). •Important causes include the 5 H's and 5 T's: •Hypoxia, Hypovolemia, Hydrogen ions (acidosis), Hyper/Hypo-kalemia, Hypothermia; •Tension pneumothorax, Tamponade-cardiac, Toxins, Thrombosis-coronary (MI), Thrombosis- pulmonary (PE). •If reversible causes are not corrected rapidly, the patient has little chance of survival. Initial management & ECG interpretation
In the ACLS Guidelines, circulation has taken a
more prominent role in the initial management of cardiac arrest. The new ‘mantra’ is: circulation, airway, breathing (C-A-B).
Once unresponsiveness is recognized,
resuscitation begins by addressing circulation (chest compressions), followed by airway opening, & then rescue breathing. Stable patients require an assessment of their electrocardiogram in order to provide appropriate treatment consistent with ACLS guidelines. Although it is best to make a definitive interpretation of the ECG prior to making management decisions, the settings in which ACLS guidelines are commonly employed require a modified, empirical approach. Such an approach is guided by the following questions: Is the rhythm fast or slow? Are the QRS complexes wide or narrow? Is the rhythm regular or irregular?
The answers to these questions often enable the clinician to
make a provisional diagnosis & initiate appropriate therapy. Airway Management During ACLS
Ventilation is performed during CPR to maintain adequate
oxygenation & eliminate carbon dioxide.
Nevertheless, during the first few minutes following sudden
cardiac arrest (SCA), oxygen delivery to the brain is limited primarily by reduced blood flow.
Therefore, in adults, the performance of excellent chest
compressions takes priority over ventilation during the initial period of basic life support. In settings with multiple rescuers or clinicians, ventilations & chest compressions are performed simultaneously. Management Of Specific Arrhythmias Ventricular fibrillation & pulseless ventricular tachycardia
VF & pulseless VT are nonperfusing rhythms
emanating from the ventricles, for which early rhythm identification, defibrillation, & CPR are the mainstays of treatment.
Early defibrillation is the most critical action in
the resuscitation effort, followed by the performance of excellent CPR. Manage potentially treatable underlying causes as appropriate. Ventricular fibrillation The ACLS Guidelines recommend the resumption of CPR immediately after defibrillation without rechecking for a pulse. CPR should not be interrupted to assess the rhythm & additional shocks should be considered no more frequently than every two minutes.
If VF or pulseless VT persists after at least one attempt at
defibrillation & two minutes of CPR, give epinephrine (1 mg IV every 3 to 5 min) while CPR is performed continuously. Evidence suggests that antiarrhythmic drugs provide little survival benefit in refractory VF or pulseless VT. Nevertheless, the current ACLS Guidelines state that they may be used in certain situations. We suggest that antiarrhythmic drugs be considered after a second unsuccessful defibrillation attempt in anticipation of a third shock. Amiodarone (300 mg IV with a repeat dose of 150 mg IV as indicated) may be administered in VF or pulseless VT unresponsive to defibrillation, CPR, & epinephrine. Lidocaine (1 to 1.5 mg/kg IV, then 0.5 to 0.75 mg/kg every 5 to 10 min) may be used if amiodarone is unavailable. Magnesium sulfate (2 g IV, followed by a maintenance infusion) may be used to treat polymorphic ventricular tachycardia consistent with torsade de pointes. Asystole & pulseless electrical activity
Pulseless electrical activity (PEA) is defined as any one of a
heterogeneous group of organized electrocardiographic rhythms without sufficient mechanical contraction of the heart to produce a palpable pulse or measurable blood pressure.
By definition, asystole & PEA are non-perfusing rhythms
requiring the initiation of excellent CPR immediately when either is present. Bradycardia Bradycardia is defined conservatively as a heart rate below 60 beats per minute, but symptomatic bradycardia generally entails rates below 50 beats per minute. Signs & symptoms of inadequate perfusion include hypotension, altered mental status, signs of shock, ongoing ischemic chest pain, & evidence of acute pulmonary edema. Hypoxemia is a common cause of bradycardia; look for signs of labored breathing (eg, increased respiratory rate, retractions, paradoxical abdominal breathing) & low oxygen saturation. Mild symptoms may not warrant treatment. Tachycardia Tachycardia is defined as a heart rate above 100 beats per minute, but symptomatic tachycardia generally involves rates over 150 beats per minute, unless underlying ventricular dysfunction exists. The fundamental approach is as follows: First determine if the patient is unstable (eg, manifests ongoing ischemic chest pain, acute mental status changes, hypotension, signs of shock, or evidence of acute pulmonary edema). Hypoxemia is a common cause of tachycardia; look for signs of labored breathing (eg, increased respiratory rate, retractions, paradoxical abdominal breathing) & low oxygen saturation. POST-RESUSCITATION CARE Important objectives for such care include: Optimizing cardiopulmonary function & perfusion of vital organs Managing acute coronary syndromes Implementing strategies to prevent & manage organ system dysfunction & injury H’s and T’s Treatable causes of cardiac arrest Hypoxia Thrombosis Hypovolemia (pulmonary) Hydrogen ion Thrombosis (coronary) (acidosis) Tamponade Hypokalemia Tension Hyperkalemia pneumothorax Hypothermia Toxins TERMINATION OF RESUSCITATIVE EFFORTS
Determining when to stop resuscitation efforts in cardiac
arrest patients is difficult Factors influencing the decision to stop resuscitative efforts include: Duration of resuscitative effort >30 min without a sustained perfusing rhythm Initial electrocardiographic rhythm of asystole Prolonged interval between estimated time of arrest & initiation of resuscitation Patient age & severity of comorbid disease Absent brainstem reflexes Normothermia 2015 ACLS Highlights CPR adjuncts Impedance threshold device (ITD) Active compression-decompression (ACD) Mechanical CPR CPR pharmacology Vasopressors Physiologic monitoring during CPR Focused ultrasound during CPR Extracorporeal CPR (ECPR) Post-cardiac arrest coronary angiography and PCI Post-cardiac arrest targeted temperature management Post-cardiac arrest neuroprognostication Mechanical CPR
Load Distributing Band Mechanical Piston
2015 AHA ECC Treatment Recommendation http://ECCGuidelines.heart.org
Standard dose epinephrine (one mg every 3 to 5 minutes)
may be reasonable for patients in cardiac arrest (Class IIb, LOE B-R). High dose epinephrine is not recommended for routine use in cardiac arrest (Class III: No Benefit, LOE B-R). It may be reasonable to administer epinephrine as soon as feasible after the onset of cardiac arrest due to an initial nonshockable rhythm (Class IIb, LOE C-LD). 2015 AHA ECC Treatment Recommendation http://ECCGuidelines.heart.org
• Vasopressin offers no advantage as a substitute for
epinephrine in cardiac arrest (Class IIb, LOE B-R). • The removal of vasopressin has been noted in the Adult Cardiac Arrest Algorithm―2015 Update. • Vasopressin in combination with epinephrine offers no advantage as a substitute for SDE in cardiac arrest (Class IIb, LOE B-R). 2015 AHA ECC Treatment Recommendation http://ECCGuidelines.heart.org
Coronary angiography should be performed
emergently (rather than later in the hospital stay or not at all) for OHCA patients with suspected cardiac etiology of arrest and ST elevation on ECG (Class I, LOE B-NR). Consistent with all other STEMI care Neurological outcomes are unknowable at time of decision Many observational studies showing high rates of good outcome after PCI, and association of successful PCI with better outcomes 2015 AHA ECC Treatment Recommendation http://ECCGuidelines.heart.org
Emergency coronary angiography is reasonable for select
(eg, electrically or hemodynamically unstable) adult patients who are comatose after OHCA of suspected cardiac origin but without ST elevation on ECG (Class IIa, LOE B-NR). Coronary angiography is reasonable in post–cardiac arrest patients for whom coronary angiography is indicated regardless of whether the patient is comatose or awake (Class IIa, LOE C-LD). thankyou